Nachrichten zur Moderna Inc. Aktie

Moderna will Zulassung für RSV-Impfstoff für Ältere beantragen

CAMBRIDGE/MÜNCHEN (dpa-AFX) - Das US-amerikanische Unternehmen Moderna will noch in der ersten Jahreshälfte eine Zulassung…

Moderna says RSV vaccine is 84% effective at preventing disease in older adults

RSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 hospitalizations, according to…

Moderna says RSV vaccine 84% effective at preventing symptoms in older adults

...By Patrick Wingrove and Leroy Leo (Reuters) - Moderna Inc said... Reuters its vaccine appears to…

Berset-Walder-Gate: Finma weitet Insider-Ermittlung aus

Hochrangige Polit-Exponenten sollen im Vorfeld der Impf-Bestellungen des Bundes im grossen Stil Biontech- und Moderna-Aktien gekauft haben. Die brisanten Emails von…

"Deeply Sinister": Big Pharma Bullied Twitter To Censor Cheap Vaccine Demands, ZeroHedge Articles

"Deeply Sinister": Big Pharma Bullied Twitter To Censor Cheap Vaccine Demands, ZeroHedge Articles …

Immunschwäche nach Corona-Impfung: Fragen zu mRNA-Präparaten

Während die Tagesschau mRNA-Präparate als Krebs-Heilmittel preist, stellen Wissenschaftler immer mehr Fragen zur neuartigen Biotechnologie. Zuletzt auch Alexander Kekulé....…

Doctor Calls For Withdrawal Of Pfizer, Moderna COVID-19 Vaccines Following New Research

Doctor Calls For Withdrawal Of Pfizer, Moderna COVID-19 Vaccines Following New Research …

Insiderhandel: Aufsichtsrat verkauft Aktien von Moderna im Wert von 1.885.700$

Afeyan, Noubar - Aufsichtsrat - Tag der Transaktion: 2023-01-11...…

Moderna Inc. stock rises Friday, outperforms market

Moderna Inc. stock rises Friday, outperforms market...…

Moderna: Kurszielerhöhung

Frankfurt (www.aktiencheck.de) - Rating-Update: Emmanuel Papadakis, Analyst der Deutschen Bank, bewertet die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol:…

Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It

Moderna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…

Daiichi Sankyo Applies for COVID-19 Vaccine Approval

Tokyo, Jan. 13 (Jiji Press)--Daiichi Sankyo Co. said Friday it has applied for health ministry approval for a COVID-19…

Moderna Inc. stock outperforms competitors on strong trading day

Moderna Inc. stock outperforms competitors on strong trading day...…

BioNTech und Moderna: Spannendes Duell – das ist 2023 zu erwarten

Die beiden mRNA-Impfstoff-Player BioNTech und Moderna lieferten sich während der Corona-Pandemie förmlich ein Wettrennen. BioNTech hatte dabei insbesondere, was den…

Curb Your Enthusiasm. Sell Put Options Instead.

In the absence of a clear market trend, investors would be wise to avoid big bets on the broader market.…

Moderna Inc. stock underperforms Wednesday when compared to competitors

Moderna Inc. stock underperforms Wednesday when compared to competitors...…

Moderna in pact for U.S. vaccine contract targeting Ebola

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biontech und Moderna: 40 Milliarden Dollar Cash-Reserven – Der Expansionswettlauf der Covid-Impfstoff-Pioniere

Die beiden Impfstoffhersteller bauen ihre Forschungsprogramme weiter zügig aus. Strategisch gehen Biontech und Moderna jedoch sehr unterschiedliche Wege....…

Moderna-Aktie: Wie Moderna zum Pionier der mRNA-Technologie wurde

37,5 Millionen Moderna-Impfdosen wurden, laut statista, bis November 2022 nach Deutschland geliefert. Spätestens jetzt dürfte das Biotechnologieunternehmen Moderna vielen bekannt…

Moderna Inc. stock rises Tuesday, outperforms market

Moderna Inc. stock rises Tuesday, outperforms market...…

Moderna (MRNA) Reports 2023 Business View & Pipeline Updates

Moderna (MRNA) expects to record a minimum of $5 billion in revenues from COVID vaccine sales in 2023. It also…

Sen. Bernie Sanders urges Moderna not to hike price of Covid-19 vaccines

Sanders, the incoming chair of the Senate health committee, called the price increase "outrageous" in a letter to Moderna CEO…

Sen. Sanders asks Moderna not to hike COVID vaccine price

...By Michael Erman (Reuters) - U.S. Senator Bernie Sanders sent......…

The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Starbucks, Moderna, Canadian Pacific Railway and Micron Technology

Thermo Fisher Scientific, Starbucks, Moderna, Canadian Pacific Railway and Micron Technology are included in this Analyst Blog....…

Moderna mulls Covid vaccine price hike as infections rise

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna (MRNA) Gains As Market Dips: What You Should Know

Moderna (MRNA) closed the most recent trading day at $183.95, moving +2% from the previous trading session....…

We are in discussion with the Chinese government over the Covid vaccine, says Moderna CEO

CNBCs Meg Tirrell joins Closing Bell to talk with Moderna CEO Stephane Bancel about the companys Covid vaccine sales in…

WSJ: Moderna may charge up to $130 per dose of its COVID shot

Shares of Moderna Inc. MRNA were up 2.5% in trading on Monday afternoon after the Wall Street Journal reported that…

UPDATE 1-Moderna considers pricing COVID vaccine at $110-$130 - WSJ

...(Adds details from the report, background) Jan 9 (Reuters) - Moderna... respond to a Reuters request for comment on the report. In October…

Top Stock Reports for Thermo Fisher Scientific, Starbucks & Moderna

Todays Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc. (TMO), Starbucks Corporation (SBUX)…

Moderna weighs pricing COVID-19 vaccine as much as $130 per dose - WSJ

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna considers pricing COVID vaccine at $110-$130 - WSJ

...(Reuters) - Moderna Inc is considering pricing its COVID-19 shot......…

Moderna Considers Price of $110-$130 for Covid-19 Vaccine

The commercial price for the shot is similar to Pfizers plans for after government contracting ends....…

BRIEF-Moderna Considers Price Of $110-$130 For Covid-19 Vaccine - WSJ

...Jan 9 (Reuters) - * MODERNA CONSIDERS PRICE OF $110-$130 FOR COVID-19......…

Moderna Surpasses Covid-19 Vaccine Sales Estimates. Why The Stock Didnt Rally.

The biotech said Covid-19 sales in 2022 were approximately $18.4 billion, while the consensus call on Wall Street was for…

Moderna: "equal-weight"

New York (www.aktiencheck.de) - Rating-Update: Matthew Harrison, Analyst von Morgan Stanley, stuft die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9,…

Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response

A flurry of vaccine announcements dominated pandemic headlines on Monday...…

dpa-AFX ProFeed